Cargando…

SARS-CoV-2 and enhancing antibodies

Detalles Bibliográficos
Autor principal:	Denner, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204707/ https://www.ncbi.nlm.nih.gov/pubmed/32438257 http://dx.doi.org/10.1016/j.jcv.2020.104424

Ejemplares similares

Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement
por: Zang, Jinkai, et al.
Publicado: (2020)

Neutralizing and enhancing antibodies against SARS-CoV-2
por: Liu, Yafei, et al.
Publicado: (2022)

Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions
por: Gavor, Edem, et al.
Publicado: (2020)

Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection
por: Okuya, Kosuke, et al.
Publicado: (2022)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
por: Lv, Huibin, et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

Absence of SARS‐CoV‐2 RNA and anti‐SARS‐CoV‐2 antibodies in stray cats
por: Stranieri, Angelica, et al.
Publicado: (2021)

Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
por: Yang, Yalong, et al.
Publicado: (2022)

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
por: Ricke, Darrell O.
Publicado: (2021)

Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies
por: Ziganshina, Marina M., et al.
Publicado: (2023)

Developing antibody tests for SARS-CoV-2
por: Petherick, Anna
Publicado: (2020)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
por: Lv, Huibin, et al.
Publicado: (2020)

The Antibody Response to SARS-CoV-2 Infection
por: Hueston, Linda, et al.
Publicado: (2020)

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
por: Liu, Yafei, et al.
Publicado: (2021)

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
por: Li, Dapeng, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

Longitudinal SARS-CoV-2 Antibody Avidity Responses in a SARS-CoV-2 Pregnancy Cohort
por: Cassidy, Arianna, et al.
Publicado: (2022)

Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies
por: Li, Ruofan, et al.
Publicado: (2022)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

SARS-CoV-2 and Anti-Cardiolipin Antibodies
por: Jizzini, Mazen, et al.
Publicado: (2020)

Profile of specific antibodies to the SARS-CoV-2
por: Mou, Danlei, et al.
Publicado: (2021)

Antibodies, epicenter of SARS-CoV-2 immunology
por: Pecetta, Simone, et al.
Publicado: (2021)

SnapShot: SARS-CoV-2 antibodies
por: Montefiori, David C., et al.
Publicado: (2021)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2
por: Müller, Katharina, et al.
Publicado: (2021)

Mathematical modeling the dynamics of SARS-CoV-2 infection with antibody-dependent enhancement
por: Song, Haitao, et al.
Publicado: (2022)

SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo
por: Nakayama, Emi E., et al.
Publicado: (2023)

Outliers Matter—Correlation between S1 IgG SARS-CoV-2 Antibodies and Neutralizing SARS-CoV-2 Antibodies
por: Hocher, Berthold, et al.
Publicado: (2022)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
por: Yang, Ren, et al.
Publicado: (2020)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors
por: Duan, Li-Jun, et al.
Publicado: (2022)

Competitive Immunoassay of SARS-CoV-2 Using Pig Sera-Derived Anti-SARS-CoV-2 Antibodies
por: Bong, Ji-Hong, et al.
Publicado: (2021)

Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants
por: Qu, Yuanyuan, et al.
Publicado: (2021)

SARS-CoV-2 neutralizing antibody development strategies
por: BALCIOĞLU, Bertan Koray, et al.
Publicado: (2020)

ELISA detection of SARS-CoV-2 antibodies in saliva
por: MacMullan, Melanie A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qkkrm2s47rlma0h7jvr8i8cn25